21.07.2016 Views

Vitamin D and Health

SACN_Vitamin_D_and_Health_report

SACN_Vitamin_D_and_Health_report

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

As a result, cut-offs for deficiency in these studies are very insecure <strong>and</strong> it is not possible to assess if<br />

there is a dose response relationship.<br />

6.374 Although there are many uncertainties in the data, the evidence is suggestive, overall, of an increased<br />

risk of poor musculoskeletal health at serum 25(OH)D concentrations below ~20-30 nmol/L.<br />

6.375 An additional complexity for interpretation of the data is the high inter-assay <strong>and</strong> inter-laboratory<br />

variation in serum 25(OH)D concentration measurements (see chapter 4). A range of assay methods<br />

was utilised to measure serum 25(OH)D concentration in the different studies on musculoskeletal<br />

health, which makes it difficult to compare serum 25(OH)D concentrations associated with increased<br />

risk across various studies. Since the data do not allow differentiation between a serum 25(OH)D<br />

threshold concentration of 20 vs 25 vs 30 nmol/L, the current threshold for increased risk of vitamin D<br />

deficiency, of < 25 nmol/L (DH, 1998), is retained.<br />

6.376 This threshold serum 25(OH)D concentration of < 25 nmol/L, is not diagnostic of disease but denotes<br />

the concentration below which risk of poor musculoskeletal health is increased at a population level.<br />

It could, therefore, be considered a ‘population protective’ concentration. It does not refer to the<br />

mean target serum 25(OH)D concentration for a particular life-stage group but rather the serum<br />

25(OH)D concentration that the majority (97.5%) of individuals in the UK should achieve or be above<br />

in terms of protecting their musculoskeletal health.<br />

6.377 Since the data were insufficient or inadequate to ascertain whether the threshold serum 25(OH)D<br />

concentration associated with increased risk of poor musculoskeletal health differs during pregnancy<br />

<strong>and</strong> lactation, the ’population protective’ concentration of 25 nmol/L was extended to these groups.<br />

6.378 A serum 25(OH)D concentration of ≥ 25 nmol/L was therefore selected as the basis for establishing the<br />

RNI for vitamin D; i.e., the mean vitamin D intake required to achieve a serum 25(OH)D concentration<br />

≥ 25 nmol/L by the majority (97.5%) of the population. The mean vitamin D intake refers to the mean<br />

or average intake over a period of time (e.g., one week) <strong>and</strong> takes account of day to day variations in<br />

vitamin D intake.<br />

6.379 The vitamin D intake <strong>and</strong> the summer sunshine exposure required to achieve a serum 25(OH)D target<br />

concentration of ≥ 25 nmol/L are considered in chapter 9.<br />

100

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!